abldadmin

AdvancedDx Biological Laboratories USA Inc. and Medline Industries, LP to distribute Next Generation Sequencing (NGS) Prep Kits in the U.S.

Newburyport (MA, USA) – AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories, is pleased to announce today the execution of a non-exclusive distribution agreement to confer to Medline Industries, LP (www.medline.com) the rights to promote and …

AdvancedDx Biological Laboratories USA Inc. and Medline Industries, LP to distribute Next Generation Sequencing (NGS) Prep Kits in the U.S. Read More »

AdvancedDx Biological Laboratories USA Inc. expands its logistics and storage capacity for supporting and managing third-parties’ clinical trials in the USA

Newburyport (MA, USA) – AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics S.A. (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the execution of a new agreement with VELA Diagnostics USA Inc. to expand the scope of services announced …

AdvancedDx Biological Laboratories USA Inc. expands its logistics and storage capacity for supporting and managing third-parties’ clinical trials in the USA Read More »

ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain.

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is announcing today the execution of a distribution agreement conferring to PALEX (https://www.palexmedical.com/) the rights to offer ABL Diagnostics products to laboratories in Spain. The collaboration will be carried out through a …

ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain. Read More »

Block trading of ABL Diagnostics ordinary shares (ABLD, Euronext, compartment B)

Woippy, le 4 mars 2024 à 8h ABL Diagnostics (FR001400AHX6) (“ABLD” or the “Company”) announced today that a total of three block transactions since August 2023 for a total of 59,651 shares of its common stock have been reported to ONDE, the central information filing system of the Autorité des Marchés Financiers (AMF) and are …

Block trading of ABL Diagnostics ordinary shares (ABLD, Euronext, compartment B) Read More »

Carrying Out Research About HIV Whole Genome using a Kit Now Available in the USA

Newburyport (MA, USA) – AdvancedDx Biological Laboratories USA Inc., the US affiliate of ABL Diagnostics (FR001400AHX6 – ABLD), a Euronext-listed French company, is pleased to announce the availability in the USA, of an assay enabling HIV whole genome genotyping by sequencing. DeepChek® Assay Whole Genome HIV-1 Genotyping has been developed for use with the leading next …

Carrying Out Research About HIV Whole Genome using a Kit Now Available in the USA Read More »

ABL Diagnostics and AB ANALITICA join forces to offer microbiology genotyping solutions in Italy.

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the execution of an exclusive distribution agreement to confer to AB ANALITICA (https://www.abANALITICA.com/en/) the rights to promote and commercialize ABLD assays and software systems to all laboratories …

ABL Diagnostics and AB ANALITICA join forces to offer microbiology genotyping solutions in Italy. Read More »

AdvancedDx Biological Laboratories USA Inc. announces its new temperature-controlled warehouse in the USA

Newburyport (MA, USA) – AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the opening of its new temperature-controlled warehouse in the USA, to offer its clients and partners improved quality and …

AdvancedDx Biological Laboratories USA Inc. announces its new temperature-controlled warehouse in the USA Read More »

ABL Diagnostics Webinar Series – Session II

INTRODUCING THE DEEPCHEK GENOTYPING TECHNOLOGY OVERVIEW & USERS EXPERIENCE Webinar from Tuesday January 30, 2024 – 4pm CET Revue de la Solution DeepChek Genotyping à travers un Webinaire présenté par notre équipe et par un panel d’experts :

ABL Diagnostics Webinar Series

REVUE DE LA TECHNOLOGIE DE GENOTYPAGE DEEPCHEK PRESENTATION & EXPERIENCES UTILISATEUR Webinaire réalisé le mardi 23 janvier 2024 – 10h00 CET Revue de la Solution DeepChek Genotyping à travers un Webinaire présenté par notre équipe et par un panel d’experts :

ABL Diagnostics announces new releases of its DeepChek®, ViroScore® and MicrobioChek® software platforms for microbiology clinical genotyping

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the release of new versions of its CE-IVD (In Vitro Diagnostics) DeepChek® and ViroScore® software applications (v3.30.115-ivdr). Tailored to analyze Next Generation Sequencing (NGS) and Capillary Electrophoresis …

ABL Diagnostics announces new releases of its DeepChek®, ViroScore® and MicrobioChek® software platforms for microbiology clinical genotyping Read More »